EffexorŽ XR

• Year 2000 Sales Increased 48% compared to the SSRI Market Growth of 21%

• sNDAs Filed May 2000

  • Prevention of Relapse of Depression
  • Prevention of Recurrence of Depression

• sNDA for Social Anxiety Disorder in 2001

XR Launch

GAD Indication

Previous slide

Next slide

Back to first slide

View graphic version